Lyphe Group is the UK’s medical cannabis pioneer.
Our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.
Our mission: We enable access to medical cannabis, wherever there is a patient in need.
Our vision: To be part of a world where medical cannabis use is accepted.
• Start with people: We put people first, both our patients and our staff.
• Cannabis as a force for good: We believe this plant is a medicine that enables better health.
• Best-in-class patient experience: We set the standard for outstanding service – for every patient.
• Everyday resilience: We know that blazing trails in a start-up industry requires superhuman strength.
• Normalizing medical cannabis: We support the de-stigmatization of cannabis, so patients can live prejudice free.